financetom
Business
financetom
/
Business
/
Bunge nears China ruling for $8.2 billion Viterra merger, Bloomberg News reports
News World Market Environment Technology Personal Finance Politics Retail Business Economy Cryptocurrency Forex Stocks Market Commodities
Bunge nears China ruling for $8.2 billion Viterra merger, Bloomberg News reports
Jun 11, 2025 9:54 PM

June 10 (Reuters) -

U.S. grains merchant Bunge is close to getting a

ruling from Chinese regulators on its $8.2 billion purchase of

Glencore ( GLCNF )-backed Viterra with a verdict expected within

days, Bloomberg News reported on Wednesday.

The merger, first announced in 2023, would create a

global crop trading and processing giant closer in scale to

chief rivals Archer-Daniels-Midland ( ADM ) and Cargill.

Regulatory approval in China remains among the last

remaining hurdles to the deal's closing.

Bunge and Viterra said in two separate, similarly worded

statements to Reuters that the companies were in the final stage

of regulatory approval and thanked Chinese officials for

"constructive dialogue throughout the review process."

China's commerce ministry did not immediately respond to

a Reuters request for comment.

The deal has secured most global approvals required for

the merger, including from the EU and Canada.

The completion deadline, originally scheduled for

mid-2024, has been

extended multiple times

, with the current date set for June 13.

Comments
Welcome to financetom comments! Please keep conversations courteous and on-topic. To fosterproductive and respectful conversations, you may see comments from our Community Managers.
Sign up to post
Sort by
Show More Comments
Related Articles >
Alnylam Pharma Confident in ATTR-CM Treatment's Market Potential, Cautious on Regulatory Risks, RBC Says
Alnylam Pharma Confident in ATTR-CM Treatment's Market Potential, Cautious on Regulatory Risks, RBC Says
Sep 26, 2024
03:43 PM EDT, 09/19/2024 (MT Newswires) -- Alnylam Pharmaceuticals ( ALNY ) is very confident regarding a commercial uptake of its transthyretin amyloid cardiomyopathy, or ATTR-CM, treatment but remains cautious about regulatory challenges, RBC Capital Markets said in a Thursday note. On regulatory, language was a bit more guarded (mgmt did not definitively rule out the possibility of an AdCom)...
Factbox-Hurricane Helene prompts US Gulf Coast energy facilities to scale back operations
Factbox-Hurricane Helene prompts US Gulf Coast energy facilities to scale back operations
Sep 26, 2024
(Reuters) -Energy facilities along the U.S. Gulf Coast scaled back operations and evacuated some production sites as Hurricane Helene is expected to bring catastrophic winds and storm surges to the northeastern Gulf Coast. On the forecast track, Helene will move across the eastern Gulf of Mexico on Thursday and cross the Florida Big Bend coast this evening, the National Hurricane...
ING Comments on The Euro
ING Comments on The Euro
Sep 26, 2024
06:01 AM EDT, 09/26/2024 (MT Newswires) -- The support from China's stimulus story waned on Wednesday and EUR/USD's exploration above 1.1200 proved to be very short-lived amid quarter-end US dollar (USD) buying, said ING. Investors will likely see a bit more range-bound swings around the 1.110-1.120 area in the near term unless United States data offers clearer direction to markets,...
BRIEF-Fuji Soft Inc: Board Decided To Recommend Shareholders To Tender Shares To KKR-Backed Group's First Tender Offer
BRIEF-Fuji Soft Inc: Board Decided To Recommend Shareholders To Tender Shares To KKR-Backed Group's First Tender Offer
Sep 26, 2024
Sept 26 (Reuters) - Fuji Soft Inc: * FUJI SOFT INC - BOARD DECIDED TO RECOMMEND SHAREHOLDERS TO TENDER SHARES TO KKR-BACKED GROUP'S FIRST TENDER OFFER * FUJI SOFT INC - BOARD REMAINS UNDECIDED ABOUT WHETHER TO RECOMMEND KKR-BACKED GROUP'S SECOND TENDER OFFER Source text for Eikon: Further company coverage: ...
Copyright 2023-2026 - www.financetom.com All Rights Reserved